Advertisement

Topics

TransEnterix, Inc. Reports Operating Results for the Third Quarter 2017

16:05 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Received U.S. FDA 510(k) clearance for the Senhance Surgical System October 13, 2017 Cash and Restricted Cash of over $100 million as of October 31, 2017 TransEnterix, Inc. (NYSE American:TRX...

Other Sources for this Article

For TransEnterix, Inc.
Investor Contact:
Mark Klausner, +1-443-213-0501
invest@transenterix.com
or
Media Contact:
Joanna Rice, + 1 951-751-1858
joanna@greymattermarketing.com

NEXT ARTICLE

More From BioPortfolio on "TransEnterix, Inc. Reports Operating Results for the Third Quarter 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...